National Bank of Canada
ANGO icon

National Bank of Canada’s AngioDynamics ANGO Stock Holding History

National Bank of Canada’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56.9K Buy
+5,000
New +$54.2K ﹤0.01% 1942

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

National Bank of Canada's ANGO Position: Q1 2026 in Review

National Bank of Canada opened a new position in AngioDynamics (ANGO) in Q1 2026: 5,000 shares worth $56.9K. The stake represents ﹤0.01% of the portfolio and ranks #1942 among its holdings.

147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • National Bank of Canada held 5,000 shares of AngioDynamics worth $56.9K as of Q1 2026.
  • AngioDynamics was a new National Bank of Canada position in Q1 2026.
  • AngioDynamics made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #1942 holding.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.